跳转至内容
Merck
CN
  • Persistence of a t(11;14)-positive clone in a patient with mantle cell lymphoma for 20 years.

Persistence of a t(11;14)-positive clone in a patient with mantle cell lymphoma for 20 years.

Clinical case reports (2017-04-12)
Yasuyuki Otsuka, Momoko Nishikori, Toshiyuki Kitano, Tomomi Oka, Takayuki Ishikawa, Hironori Haga, Akifumi Takaori-Kondo
摘要

We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non-nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases.

材料
货号
品牌
产品描述

Sigma-Aldrich
抗-SOX11 兔抗, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution